These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12378579)

  • 1. Second trimester trisomy 21 maternal serum marker screening. Results of a countrywide study of 854,902 patients.
    Muller F; Forestier F; Dingeon B;
    Prenat Diagn; 2002 Oct; 22(10):925-9. PubMed ID: 12378579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of prenatal follow-up strategies for trisomy 21 affected pregnancies in France].
    Dupont JM; Simon-Bouy B; Zebina A; Pessione F; Royère D; Doco-Fenzy M;
    Gynecol Obstet Fertil Senol; 2017 Mar; 45(3):152-157. PubMed ID: 28258854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triploidy identified through second-trimester serum screening.
    Huang T; Alberman E; Wald N; Summers AM
    Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on key techniques and intervention in reducing birth defects].
    Zhu BS; Su J; Lu XH; He J; Zhu S; Jiao CX; Zhang JM; Tang XH; Tao Y; Lin KP; Chen H; Li SY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):658-63. PubMed ID: 22176989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results.
    Benn PA; Ying J; Beazoglou T; Egan JF
    Prenat Diagn; 2001 Jan; 21(1):46-51. PubMed ID: 11180240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second-trimester Down syndrome maternal serum screening in twin pregnancies: impact of chorionicity.
    Muller F; Dreux S; Dupoizat H; Uzan S; Dubin MF; Oury JF; Dingeon B; Dommergues M
    Prenat Diagn; 2003 Apr; 23(4):331-5. PubMed ID: 12673641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prenatal serum screening of aneuploidy and of neural tube defects in the second trimester of pregnancy among the population of Luxembourg. Evaluation of risk by the triple test (AFP+THCG+UE3)].
    Thix J
    Bull Soc Sci Med Grand Duche Luxemb; 1997; 134(1):25-9. PubMed ID: 9303823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Second trimester maternal serum screening for Down's syndrome in women of advanced maternal age: a multi-center prospective study].
    Qi QW; Jiang YL; Liu JT; Bian XM; Li Y; Lü SM; Zhu BS; Wang H; Xu ZF; Pan XY; Cai Y
    Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):737-41. PubMed ID: 19087538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential pathways of testing after first-trimester screening for trisomy 21.
    Platt LD; Greene N; Johnson A; Zachary J; Thom E; Krantz D; Simpson JL; Silver RK; Snijders RJ; Goetzl L; Pergament E; Filkins K; Mahoney MJ; Hogge WA; Wilson RD; Mohide P; Hershey D; MacGregor S; Bahado-Singh R; Jackson LG; Wapner R;
    Obstet Gynecol; 2004 Oct; 104(4):661-6. PubMed ID: 15458882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [How to improve the screening and diagnosis of fetal aneuploidy?].
    Ville Y
    Bull Acad Natl Med; 2005 Nov; 189(8):1773-84; discussion 1784-7. PubMed ID: 16737102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Maternal biochemical screening -- an approach for genetic prevention. part 1. first and second trimester screening].
    Angelova L; Gadancheva V; Konstantinova D; Stoianova M; Hachmerian M; Yakov B; Kremenski I
    Akush Ginekol (Sofiia); 2013; 52(5):8-13. PubMed ID: 24501862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the association of a serum marker and second trimester ultrasonography for the screening of trisomy 21 in women of less than 38 years. Prospective study of 5,163 patients].
    Lefebvre G; Vauthier-Brouzes D; Choukroun JB; Sebagh E; Bernard M; Brochet C; Lesourd S; Darbois Y
    J Gynecol Obstet Biol Reprod (Paris); 1998 Oct; 27(6):599-604. PubMed ID: 9854223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
    Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
    Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening.
    Nicolaides KH; Spencer K; Avgidou K; Faiola S; Falcon O
    Ultrasound Obstet Gynecol; 2005 Mar; 25(3):221-6. PubMed ID: 15736186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal serum second trimester screening for chromosomal disorders and neural tube defects in a government hospital of North India.
    Kaur G; Srivastav J; Kaur A; Huria A; Goel P; Kaur R; Kataria S; Chavan BS; Kochhar S; Aggarwal P; Kaur N; Panigrahi I; Chawla P
    Prenat Diagn; 2012 Dec; 32(12):1192-6. PubMed ID: 23055346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Maternal serum screening for Down syndrome and neural tube defects].
    van Rijn M; Christiaens GC; van der Schouw YT; Hagenaars AM; de Pater JM; Visser GH
    Ned Tijdschr Geneeskd; 1998 Feb; 142(8):409-15. PubMed ID: 9562776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down syndrome maternal serum marker screening after 18 weeks of gestation: a countrywide study.
    Dreux S; Nguyen C; Czerkiewicz I; Schmitz T; Azria E; Fouré MA; Muller F;
    Am J Obstet Gynecol; 2013 May; 208(5):397.e1-5. PubMed ID: 23353023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal maternal serum screening during the second trimester of pregnancy using the Triple Test in Luxembourg.
    Thix J
    Bull Soc Sci Med Grand Duche Luxemb; 2006; (3):387-405. PubMed ID: 17209295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second trimester two-step trisomy 18 screening using maternal serum markers.
    Muller F; Sault C; Lemay C; Roussel-Mizon N; Forestier F; Frendo JL;
    Prenat Diagn; 2002 Jul; 22(7):605-8. PubMed ID: 12124697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.